₹
5.67
May 21
Business Description
Welcure Drugs & Pharmaceuticals Ltd
ISIN : INE331C01017
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.99 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 5/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -130.5 | |||||
3-Year EPS without NRI Growth Rate | -84.7 | |||||
3-Year Book Growth Rate | 367.1 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 86.44 | |||||
9-Day RSI | 77.56 | |||||
14-Day RSI | 70.99 | |||||
6-1 Month Momentum % | 8.64 | |||||
12-1 Month Momentum % | 13.11 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.95 | |||||
Quick Ratio | 3.95 | |||||
Cash Ratio | 2.13 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -3.17 | |||||
ROA % | -3.05 | |||||
ROIC % | -18.37 | |||||
ROC (Joel Greenblatt) % | -474.75 | |||||
ROCE % | -19.91 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 79.86 | |||||
Shiller PE Ratio | 210.57 | |||||
PB Ratio | 5.53 | |||||
Price-to-Tangible-Book | 5.5 | |||||
Price-to-Free-Cash-Flow | 70.88 | |||||
Price-to-Operating-Cash-Flow | 70.88 | |||||
EV-to-EBIT | -27.03 | |||||
EV-to-EBITDA | -28.89 | |||||
EV-to-FCF | 64.72 | |||||
Price-to-Projected-FCF | 5.3 | |||||
Price-to-Net-Current-Asset-Value | 141.75 | |||||
Price-to-Net-Cash | 283.5 | |||||
Earnings Yield (Greenblatt) % | -3.69 | |||||
FCF Yield % | 1.4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Welcure Drugs & Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | |||
EPS (TTM) (₹) | 0.071 | ||
Beta | -0.57 | ||
Volatility % | 39.06 | ||
14-Day RSI | 70.99 | ||
14-Day ATR (₹) | 0.213604 | ||
20-Day SMA (₹) | 4.7765 | ||
12-1 Month Momentum % | 13.11 | ||
52-Week Range (₹) | 3.2 - 5.67 | ||
Shares Outstanding (Mil) | 13.51 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Welcure Drugs & Pharmaceuticals Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Welcure Drugs & Pharmaceuticals Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Welcure Drugs & Pharmaceuticals Ltd Frequently Asked Questions
What is Welcure Drugs & Pharmaceuticals Ltd(BOM:524661)'s stock price today?
When is next earnings date of Welcure Drugs & Pharmaceuticals Ltd(BOM:524661)?
Does Welcure Drugs & Pharmaceuticals Ltd(BOM:524661) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |